Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.

Weng KP, Hsieh KS, Huang SH, Ou SF, Lai TJ, Tang CW, Lin CC, Ho TY, Liou HH, Ger LP.

J Chin Med Assoc. 2013 Aug;76(8):438-45. doi: 10.1016/j.jcma.2013.04.005. Epub 2013 Jun 13.

2.

Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.

Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.

Arthritis Rheum. 2013 Mar;65(3):805-14. doi: 10.1002/art.37815.

3.

Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.

Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.

Kaohsiung J Med Sci. 2012 Jan;28(1):23-9. doi: 10.1016/j.kjms.2011.09.002. Epub 2011 Dec 11.

4.

Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.

Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD.

J Microbiol Immunol Infect. 2007 Oct;40(5):395-400.

PMID:
17932598
5.

[The role of endogenous vascular elastase in coronary artery reconstruction in Kawasaki disease].

Liu YL, Wang XM, Li Y, Shi K, Guo YH, Yang YF, Chen TT.

Zhongguo Dang Dai Er Ke Za Zhi. 2014 Apr;16(4):389-92. Chinese.

6.

Serum levels of interleukin-18 are elevated in the subacute phase of kawasaki syndrome.

Nomura Y, Masuda K, Maeno N, Yoshinaga M, Kawano Y.

Int Arch Allergy Immunol. 2004 Oct;135(2):161-5. Epub 2004 Sep 2.

PMID:
15345916
7.

Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.

Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.

Pediatr Rheumatol Online J. 2017 Mar 21;15(1):17. doi: 10.1186/s12969-017-0149-1.

8.

Association between adipokines and coronary artery lesions in children with Kawasaki Disease.

Kim HJ, Choi EH, Kil HR.

J Korean Med Sci. 2014 Oct;29(10):1385-90. doi: 10.3346/jkms.2014.29.10.1385. Epub 2014 Oct 8.

9.

[Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].

Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.

Zhongguo Dang Dai Er Ke Za Zhi. 2006 Jun;8(3):208-10. Chinese.

PMID:
16787593
10.

Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.

Chen YL, Wang JL, Li WQ.

Eur J Pediatr. 2014 Nov;173(11):1467-71. doi: 10.1007/s00431-014-2346-y. Epub 2014 Jun 3.

11.

Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease.

Gong F, Zhang Y, Xie C, Zhu W, Wang W, Fu S, Shen H.

Pediatr Res. 2012 Jun;71(6):720-4. doi: 10.1038/pr.2012.27. Epub 2012 Feb 15.

PMID:
22337222
12.

Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.

Giannouli G, Tzoumaka-Bakoula C, Kopsidas I, Papadogeorgou P, Chrousos GP, Michos A.

Pediatr Cardiol. 2013 Aug;34(6):1476-81. doi: 10.1007/s00246-013-0673-9. Epub 2013 Mar 6.

PMID:
23463134
13.

Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.

Kuo HC, Yang YL, Chuang JH, Tiao MM, Yu HR, Huang LT, Yang KD, Chang WC, Lee CP, Huang YH.

J Clin Immunol. 2012 Aug;32(4):746-52. doi: 10.1007/s10875-012-9668-1. Epub 2012 Mar 6.

PMID:
22392047
14.

[Association study of a functional SNP rs28493229 of ITPKC gene and Kawasaki disease in a Chinese population].

Peng Q, Chen CH, Wu Q, Li B, Liao J, Luo CD, Hu XP, Zheng Z, He HL, Zhang Y.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Dec;28(6):644-8. doi: 10.3760/cma.j.issn.1003-9406.2011.06.010. Chinese.

PMID:
22161096
15.

Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions.

Furui J, Ishii M, Ikeda H, Muta H, Egami K, Sugahara Y, Himeno W, Akagi T, Kato H, Matsuishi T.

Acta Paediatr. 2002;91(11):1183-8.

PMID:
12463316
16.

Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.

Simonini G, Masi L, Giani T, Piscitelli E, Cimaz R, Vierucci S, Brandi ML, Falcini F.

J Rheumatol. 2005 Nov;32(11):2233-8.

PMID:
16265708
18.

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease.

Qi Y, Gong F, Zhang Q, Xie C, Wang W, Fu S.

Arthritis Res Ther. 2012 Nov 21;14(6):R251. doi: 10.1186/ar4094.

19.

Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.

Ge X, Li CR, Yang J, Wang GB.

Scand J Immunol. 2013 May;77(5):389-97. doi: 10.1111/sji.12022.

20.

S100A12 on circulating endothelial cells surface in children with Kawasaki disease.

Fu S, Gong F, Xie C, Zhu W, Wang W, Shen H, Tang Y.

Pediatr Res. 2010 Aug;68(2):165-8. doi: 10.1203/00006450-201011001-00321.

PMID:
20461025

Supplemental Content

Support Center